Meyka Pro banner
Nyxoah S.A.

Nyxoah S.A. (NYXH) Stock Overview

Explore Nyxoah S.A.’s financial performance, market position, analyst ratings, and future outlook.

NYXHNASDAQ
HealthcareMedical - Specialties
$1.50
$0.02(1.32%)
U.S. Market opens in 12h 49m

Nyxoah S.A. (NYXH)

Meyka AI Score

Z

Key Financials

Market Cap150.1M
P/E Ratio-0.60
EPS (TTM)$-2.52
ROE-1.80%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.02
3 Months$0.00
1 Year Target$0.00

NYXH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Nyxoah S.A. (NASDAQ: NYXH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Nyxoah S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NYXH on the NASDAQ shows an RSI of 45.96, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Nyxoah S.A.'s NASDAQ-traded stock include a P/E ratio of -0.60 and a market capitalization of 150.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NYXH on the NASDAQ.

Price Performance (NASDAQ: NYXH)

1-Day Change
-1.32%
5-Day Change
-13.79%
1-Month Change
-5.06%
3-Month Change
14.50%
6-Month Change
-57.63%
Year-to-Date (YTD) Change
-67.39%
1-Year Change
-73.07%
3-Year Change
-81.73%
5-Year Change
-95.02%
All-Time (Max) Change
-93.75%

Contact Information

32 1 022 23 55
Rue Edouard Belin 12, Mont-Saint-Guibert, WA, 1435

Company Facts

1,540 Employees
IPO DateApr 28, 2021
CountryBE
Actively Trading

Frequently Asked Questions